Chiesi USA, Inc. 2026-07-22 Health serious FDA
Health · FDA · Recall #FDA-D-0689-2026
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use… Recall
Issued July 22, 2026 · Chiesi USA, Inc.
In July 2026, Chiesi USA, Inc. recalled the CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use…, a serious health recall reported by the FDA.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Chiesi USA, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Chiesi USA, Inc.
- Category
- Health
- Recall date
- July 22, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0689-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Chiesi USA, Inc. has 1 recall in our database.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.